Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Visual pigment formation" refers to the cyclic regeneration of visual chromophore (11-cis-retinal) via the classical visual cycle and auxiliary pathways, involving proteins such as enzymes (e.g., RPE65 isomerase), binding proteins, and transporters[1][3][7]. This process is essential for sustaining vision as it enables photoreceptors to continually respond to light by replenishing the chromophore component of visual pigments. Disturbances in this cycle can cause severe inherited retinal diseases and are the subject of investigation as drug targets in some retinal disorders.
Drugs targeting this pathway mostly act as: Enzyme inhibitors (e.g., inhibition of RPE65 reduces toxic byproducts of the visual cycle)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Visual pigment formation.